Godavari Drugs Limited (BOM:530317)

India · Delayed Price · Currency is INR

125.18

+15.31 (13.93%)

At close: Sep 25, 2026

Market Cap	1.27B +102.7%
Revenue (ttm)	1.11B +5.4%
Net Income	41.58M +9.7%
EPS	5.03 -0.0%
Shares Out	10.13M
PE Ratio	24.88
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	55,906
Open	111.50
Previous Close	109.87
Day's Range	111.50 - 130.90
52-Week Range	69.70 - 135.25
Beta	0.49
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin hydrochloride (HCL), ciprofloxacin lactate, ciprofloxacin betaine, carbamazepine, enrofloxacin, mefenamic acid, ambroxol hydrochloride, piracetam, as well as 2,5-dihydroxy-1,4- dithiane. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs Limited was inc... [Read more]

Industry Pharmaceutical Preparations

Founded 1987

Employees 112

Stock Exchange Bombay Stock Exchange

Ticker Symbol 530317

Full Company Profile

Financial Performance

In fiscal year 2026, Godavari Drugs's revenue was 1.06 billion, a decrease of -6.65% compared to the previous year's 1.13 billion. Earnings were 40.89 million, a decrease of -6.64%.

Financial Statements